- 1 Information on public consultation
- 1.1 Public consultation dates
- 1.2 How to submit comments
- 1.3 General Information on how to comment
- 1.4 How we respond to comments and what we won't accept
- 1.5 How we respond to additional/new evidence suggestions
- 1.6 Problems submitting a comment?
- 1.7 Ongoing consultation
Information on public consultation
Public consultation dates
These guidelines are open for public comment from the period of Friday 30 October 2015 to Friday 13 November 2015.
Comments can be made at a later date during the ongoing consultation phase.
How to submit comments
Step 1: Create a user account
Before you comment, we recommend you create a user account by completing the online registration form. Once done, you will be logged in automatically and directed back to this page.
If you have a user account on our website, your comments will be attributed to you. You can also receive alerts updating you on any replies to your comments.
You can omit this step and choose to comment anonymously. However, this means that we won't be able to notify you and let you know how the working group addressed your comment.
Browse and review the Teleoncology Guidelines content.
Click the blue comment button to expand the comment section and follow the prompts.
You can attach references as part of your comment.
General Information on how to comment
- If you have identified any gaps or errors in the content please suggest suitable text for inclusion.
- Statements regarding the inclusion or exclusion of issues should be clearly supported by scientific evidence.
Comments on language and terminology
- If you have comments on the language and terminology of the guidelines please suggest replacement text.
How we respond to comments and what we won't accept
How we respond to comments:
- All comments will be screened by the Project Manager, Clinical Oncology Society of Australia and any inappropriate comments will be removed.
- Minor changes (e.g. correcting a typographical error) may be made immediately.
- At the end of the consultation period all relevant comments will be reviewed by the Teleoncology Guidelines Working Group.
- COSA reserves the right to summarise and edit comments received during consultation, or not to publish them at all, where in reasonable opinion of COSA, the comments are voluminous, publication would be unlawful or publication would be otherwise inappropriate.
- Relevant comments and the working groups response will be published on this wiki with the guidelines.
We are unable to accept:
- Comments that are not made using the Wiki
- Confidential information or personal medical information about yourself or another person from which you or the other person’s identity could be ascertained.
How we respond to additional/new evidence suggestions
- All comments will be screened by our Project Manager who is responsible for literature searches and evidence updates.
- If the evidence meets the inclusion and exclusion criteria of the associated clinical question, a critical appraisal of the study publication will be forwarded to the authors for further review.
- Once you have submitted new evidence, you will also be instructed how you can track the status of your submission and find out what happened to your submission.
Problems submitting a comment?
If you have difficulties making a comment please contact the Manager, Clinical Guidelines Network, Cancer Council Australia at guidelines(at)cancer.org.au
These guidelines will be updated regularly and it is possible to submit comments on an ongoing basis. Authors will process and review comments as they come in. See Clinical Practice Guideline Development Handbookon the procedures for literature updates and processing of comments after a guideline has been launched.